Nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nanoparticle albumin-bound paclitaxel (nab-paclitaxel), covering 2017-03-31 to 2017-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer [Phase 1]